Single-Cell RNA Sequencing (scRNA-seq) in Cardiac Tissue: Applications and Limitations

Cardiovascular diseases (CVDs) are a group of disorders of the blood vessels and heart, which are considered as the leading causes of death worldwide.The pathology of CVDs could be related to the functional abnormalities of multiple cell types in the heart.Single-cell RNA sequencing (scRNA-seq) technology is a powerful method for characterizing individual cells and elucidating the molecular mechanisms by providing a high resolution of transcriptomic changes at the single-cell level.Specifically, scRNA-seq has provided novel insights into CVDs by identifying rare cardiac cell types, inferring the trajectory tree, estimating RNA velocity, elucidating the cell-cell communication, and comparing healthy and pathological heart samples.In this review, we summarize the different scRNAseq platforms and published single-cell datasets in the cardiovascular field, and describe the utilities and limitations of this technology.Lastly, we discuss the future perspective of the application of scRNA-seq technology into cardiovascular research.